Add Yahoo as a preferred source to see more of our stories on Google. The executive who guided classic American whiskeys Jim Beam and Maker's Mark through the transition of being acquired by a ...

Beam Therapeutics specializes in gene-editing medicines, and recently, the company's Senior Vice President edited out thousands of shares from her portfolio.

“We look forward to sharing more about Beam and our vision for interactive game streaming in the future.” Microsoft has acquired video game livestreaming company Beam. Beam describes itself as an ...

Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the best oversold NASDAQ stocks to buy now. On July 1, Beam Therapeutics Inc. (NASDAQ:BEAM) announced an Agreement and Plan of Merger under which it ...

Leerink Partners analyst Mani Foroohar has maintained their neutral stance on BEAM stock, giving a Hold rating on August 7. Mani Foroohar’s rating is based on a careful evaluation of Beam Therapeutics ...

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem ...

Beam Global (NASDAQ:BEEM) shares are trading higher after the close Monday on the heels of the company's first-quarter report. What Happened: Beam said first-quarter revenue increased 245% ...

Beam, a new startup looking to help general contractors with all things finance, has announced a $4 million seed funding round. The funding round was led by Accel, with participation from Susa, ...

The executive who guided classic American whiskeys Jim Beam and Maker's Mark through the transition of being acquired by a Japanese company four years ago has announced he'll step down as CEO of ...